Leveljump Healthcare Corp. (JMPHF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.2 Million CAD | 106.31% |
| 2022 | -546.69 Thousand CAD | 74.54% |
| 2021 | -2.15 Million CAD | -0.05% |
| 2020 | -2.14 Million CAD | -1077.15% |
| 2019 | 219.62 Thousand USD | 2297.15% |
| 2018 | -9996.00 CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 662.71 Thousand CAD | 1615.7% |
| 2024 Q1 | 98.06 Thousand CAD | -80.3% |
| 2023 Q2 | -179.62 Thousand USD | -117.53% |
| 2023 Q1 | -82.57 Thousand CAD | -113.19% |
| 2023 FY | - CAD | 106.31% |
| 2023 Q4 | 225.15 Thousand CAD | 399.03% |
| 2023 Q3 | -75.29 Thousand USD | 58.08% |
| 2022 Q3 | -115.09 Thousand CAD | -23.59% |
| 2022 Q2 | -93.12 Thousand CAD | 53.76% |
| 2022 Q1 | -201.37 Thousand CAD | 55.62% |
| 2022 FY | - CAD | 74.54% |
| 2022 Q4 | -38.73 Thousand CAD | 66.35% |
| 2021 Q2 | -574.08 Thousand CAD | 17.65% |
| 2021 Q3 | -413.96 Thousand CAD | 27.89% |
| 2021 Q4 | -453.76 Thousand CAD | -9.62% |
| 2021 FY | - CAD | -0.05% |
| 2021 Q1 | -697.08 Thousand CAD | -1269.01% |
| 2020 FY | - CAD | -1077.15% |
| 2020 Q4 | -50.91 Thousand CAD | -174.65% |
| 2020 Q3 | 68.21 Thousand CAD | 154.22% |
| 2020 Q2 | 26.83 Thousand CAD | -62.84% |
| 2020 Q1 | 72.2 Thousand CAD | 774.51% |
| 2019 Q2 | 164.26 Thousand CAD | 103.89% |
| 2019 Q4 | -10.7 Thousand CAD | -109.72% |
| 2019 Q1 | 80.56 Thousand CAD | 0.0% |
| 2019 Q3 | 110.15 Thousand CAD | -32.94% |
| 2019 FY | - USD | 2297.15% |
| 2018 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Bio Medica Corporation | -1.16 Million USD | -3.248% |
| Arrayit Corporation | -3.07 Million USD | 60.982% |
| Atlantic International Corp. | -5.38 Million USD | 77.72% |
| Biocept, Inc. | -30.24 Million USD | 96.029% |
| Bioqual, Inc. | 3.03 Million USD | 139.6% |
| CardioGenics Holdings Inc | -757.37 Thousand USD | -58.544% |
| DermTech, Inc. | -97.89 Million USD | 98.773% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 100.041% |
| HTG Molecular Diagnostics, Inc. | -20.24 Million USD | 94.068% |
| iMD Companies, Inc. | -154.65 Thousand USD | -676.398% |
| IDenta Corp. | 71.58 Thousand USD | 1777.356% |
| Interpace Biosciences, Inc. | 3.83 Million USD | 131.294% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 3203.564% |
| InVitro International | 6680.00 USD | 18075.584% |
| Lumos Diagnostics Holdings Limited | -5.43 Million USD | 77.911% |
| Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | -9795.904% |
| Medical Imaging Corp. | -896.74 Thousand USD | -33.904% |
| NovelStem International Corp. | -3.78 Million USD | 68.282% |
| Optigenex Inc. | -1.18 Million USD | -1.184% |
| PharmChem, Inc. | 1.05 Million USD | 213.945% |
| Proteome Sciences plc | -1.13 Million USD | -5.609% |
| Response Genetics, Inc | -19.66 Million USD | 93.894% |
| Rennova Health, Inc. | -234.81 Thousand USD | -411.368% |
| RushNet, Inc. | -614.85 Thousand USD | -95.294% |
| ScreenPro Security Inc. | -3.43 Million USD | 65.042% |
| Stella Diagnostics Inc. | -5.7 Million USD | 78.961% |
| StageZero Life Sciences Ltd. | -10.27 Million USD | 88.308% |
| Todos Medical Ltd. | -9.39 Million USD | 87.218% |